About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Tackling Multiple Sclerosis Earlier On Slows Progression

by VR Sreeraman on August 3, 2007 at 7:55 PM
Font : A-A+

Tackling Multiple Sclerosis Earlier  On Slows Progression

Early use of the drug interferon beta-1b can significantly delay progression of multiple sclerosis (MS), according to a study published in this Saturday's Lancet.

Swiss doctors conducted a trial among 468 patients diagnosed with early symptoms of MS, of whom 292 received the drug and 176 received a dummy, called a placebo.

Advertisement

Each volunteer was given an injection every other day for two years or until he or she was diagnosed with a clinically definite case of MS, a judgement based on worsening disability.

Using an internationally accepted scale of symptoms, the researchers found that among the "early treatment" group the drug reduced the risk of developing clinically definite MS by 41 percent.
Advertisement

In MS, the immune system attacks myelin, the fatty sheath that protects the cells of the central nervous system.

As a result, nerve signals get slowed or blocked, causing difficulties in movement and coordination, muscle weakness, cognitive impairment, slurred speech and vision problems.

The research was led by Ludwig Kappos of University Hospital Petersgraben in Basel.

Interferon beta-1b, marketed as Betaseron, is a member of the interferon family of drugs. It is already licensed for treating MS, and works by apparently reducing inflammation.

Source: AFP
LIN/B
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Advertisement
News Category
What's New on Medindia
Woman with Rare Spinal Cord Defect from Birth Sues Doctor
Toothache
World AIDS Day 2021 - End Inequalities, End AIDS
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Iodine Deficiency Disorder Chemotherapy Chemotherapy Drugs Multiple Sclerosis Infectious Mononucleosis Multiple Sclerosis Treatment and Modify Optic Neuritis Autoimmune Disorders Health Risks of Eating Pork 

Recommended Reading
Scientists Identify New Genetic Risk Factors for Multiple Sclerosis
Investigators on Sunday reported the biggest breakthrough in decades into the genetic drivers for .....
New Imaging Technique may Help Detect Multiple Sclerosis Early
Purdue University researchers say that new imaging technique, called coherent anti-Stokes Raman ......
Autoimmune Response in Multiple Sclerosis
In multiple sclerosis (MS), the myelin that surrounds the axons of nerve cells is attacked by the .....
Autoimmune Disorders
Autoimmune disorders occur when the immune system fails to recognize the body as ‘self’ and attacks ...
Chemotherapy
‘Chemo’ means medicine or ‘drug’; ‘therapy’ means ‘treatment’. Chemotherapy refers to the use of cy...
Chemotherapy Drugs
Chemotherapy drugs perform like ‘magic bullets’ to destroy cancer cells in the body....
Health Risks of Eating Pork
Pork is one of the most popular and widely consumed of all red meats, but how healthy is it? Find ou...
Infectious Mononucleosis
Called also the kissing diesase, Mononucleosis is an infectious disease due to infection with the Ep...
Iodine Deficiency Disorder
To control IDD, the ‘National Goiter Control Program (NGCP)’ was launched which was later renamed as...
Multiple Sclerosis
Multiple sclerosis can be a severely disabling autoimmune disease that affects the myelin or insulat...
Multiple Sclerosis Treatment and Modify
Multiple sclerosis is treated with drugs that modify the course of the disease, suppress immunity an...
Optic Neuritis
Optic neuritis is acute inflammation of the optic nerve. Optic nerve connects the eye to the brain a...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use